WHO + WHY? When looking back at M+A activity this year, I took notice of a few that stood out, irrespective of their size. Unlike many previous years, there was significant disruption and tons of pivoting due to the challenges of COVID-19. Were you able to predict...
McDermott + Bull has successfully placed Bill Ricketts, Ph.D., as the Head of Clinical Development and Carol Chen, Ph.D., as the Director of Clinical Development for Karius. They will lead and execute the company’s pivotal trials and will be responsible for driving...
McDermott + Bull has successfully placed Avyaya (Avi) Sharma as the Vice President of Clinical Affairs at Adagio Medical, Inc. He will be charged with overseeing and managing the company’s sponsored global pre-market and post-market clinical studies and is currently...
McDermott + Bull has successfully placed Scott VanderMeer as the Vice President of Sales at Clarius Mobile Health. As a member of Clarius’s senior leadership team, Scott will play a vital role in achieving commercial success through revenue and market share...
McDermott + Bull has successfully placed Genèse Castonguay as the Vice President of Marketing at Clarius Mobile Health. As a member of Clarius’ senior leadership team, Genèse will play an instrumental role in establishing the company as a leading brand in handheld...
McDermott + Bull has successfully placed Mark Hughes as the Vice President of Manufacturing for iRhythm Technologies. While leading the company’s execution of an aggressive plan to further grow the company, Mark will provide the vision, leadership, and mentorship...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policyOkNo
